Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Beacon Therapeutics (USA) Inc formerly Applied Genetic Technologies Corp, is an ophthalmic gene therapy company for prevalent and rare retinal diseases that result in blindness. The company's pipeline product include AGTC-501 for the treatment of x-linked retinitis pigmentosa (XLRP); CDHR1 which treats cone rod dystrophy (CRD). It also focuses on therapeutic area such as dry age-related macular degeneration (dAMD). The company uses Adeno-associated virus (AAV) to deliver gene constructs that encode therapeutic proteins in order to address retinal disorders. It operates in the US and the UK. Beacon is headquartered in Alachua, Florida, the US.
Headquarters
United States of America
Address
Suite #10, 14193 NW 119th Terrace, Alachua, Florida, 32615
Website
www.beacontx.com
Telephone
1 386 4622204
No of Employees
102
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$330,000
Products and Services
| Products | Services |
|---|---|
| Pipeline | Clinical Trials |
| AGTC-501 - X-Linked Retinitis Pigmentosa (XLRP) | |
| CDHR1 - Cone Rod Dystrophy (CRD) |
Competitor Comparison
| Key Parameters | Beacon Therapeutics (USA) Inc | International Stem Cell Corp | Kubota Vision Inc | Cytodyn Inc |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | Alachua | San Diego | Seattle | Vancouver |
| State/Province | Florida | California | Washington | Washington |
| No. of Employees | 102 | 32 | - | 13 |
| Entity Type | Private | Public | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| David Fellows | Chairman | Executive Board | - | - |
| Lance Baldo, M.D | Chief Executive Officer; Director | Executive Board | - | - |
| Thomas Biancardi | Chief Financial Officer | Senior Management | - | - |
| Daniel Chung | Chief Medical Officer | Senior Management | - | - |
| Abraham Scaria | Chief Scientific Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer